Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M GIRARD

Showing results (891-900 of 920) with videos related to

Pageof 92
Sort By:
Journal of Virology|February 11, 2021
A Randomized Placebo-Controlled Efficacy Study of a Prime Boost Therapeutic Vaccination Strategy in HIV-1-Infected Individuals: VRI02 ANRS 149 LIGHT Phase II TrialY Lévy, C Lacabaratz, E Lhomme, et al.
Plos Pathogens|August 30, 2023
Correction: How much (ATP) does it cost to build a trypanosome? A theoretical study on the quantity of ATP needed to maintain and duplicate a bloodstream-form Trypanosoma brucei cellJanaina F Nascimento, Rodolpho O O Souza, Mayke B Alencar, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|October 27, 2020
A Bayesian multilevel analysis of the longitudinal associations between relationship quality and suicidal ideation and attempts among youth with bipolar disorderCraig J R Sewall, Jeffrey M Girard, John Merranko, et al.
European Journal of Neurology|October 10, 2018
Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort studyJ Lorscheider, J Kuhle, G Izquierdo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 22, 2011
The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitudeJ Lechner-Scott, B Spencer, T de Malmanche, et al.
HIV Medicine|December 8, 2017
Efficacy, safety and patient-reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study)E Rosenthal, C Fougerou-Leurent, A Renault, et al.
Journal of Medical Economics|December 12, 2023
Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United KingdomT Spelman, W L Herring, C Acosta, et al.
BMC Medical Research Methodology|May 31, 2022
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosisM Lefort, S Sharmin, J B Andersen, et al.
Physical Review Letters|December 27, 2015
Observation of Transverse Spin-Dependent Azimuthal Correlations of Charged Pion Pairs in p^{↑}+p at sqrt[s]=200  GeVL Adamczyk, J K Adkins, G Agakishiev, et al.
Physical Review Letters|April 16, 2016
Measurement of the Transverse Single-Spin Asymmetry in p^{↑}+p→W^{±}/Z^{0} at RHICL Adamczyk, J K Adkins, G Agakishiev, et al.
Pageof 92

Showing results (891-900 of 920) with videos related to

Sort By:
Pageof 92
Journal of Virology|February 11, 2021
A Randomized Placebo-Controlled Efficacy Study of a Prime Boost Therapeutic Vaccination Strategy in HIV-1-Infected Individuals: VRI02 ANRS 149 LIGHT Phase II TrialY Lévy, C Lacabaratz, E Lhomme, et al.
Plos Pathogens|August 30, 2023
Correction: How much (ATP) does it cost to build a trypanosome? A theoretical study on the quantity of ATP needed to maintain and duplicate a bloodstream-form Trypanosoma brucei cellJanaina F Nascimento, Rodolpho O O Souza, Mayke B Alencar, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|October 27, 2020
A Bayesian multilevel analysis of the longitudinal associations between relationship quality and suicidal ideation and attempts among youth with bipolar disorderCraig J R Sewall, Jeffrey M Girard, John Merranko, et al.
European Journal of Neurology|October 10, 2018
Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort studyJ Lorscheider, J Kuhle, G Izquierdo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 22, 2011
The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitudeJ Lechner-Scott, B Spencer, T de Malmanche, et al.
HIV Medicine|December 8, 2017
Efficacy, safety and patient-reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study)E Rosenthal, C Fougerou-Leurent, A Renault, et al.
Journal of Medical Economics|December 12, 2023
Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United KingdomT Spelman, W L Herring, C Acosta, et al.
BMC Medical Research Methodology|May 31, 2022
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosisM Lefort, S Sharmin, J B Andersen, et al.
Physical Review Letters|December 27, 2015
Observation of Transverse Spin-Dependent Azimuthal Correlations of Charged Pion Pairs in p^{↑}+p at sqrt[s]=200  GeVL Adamczyk, J K Adkins, G Agakishiev, et al.
Physical Review Letters|April 16, 2016
Measurement of the Transverse Single-Spin Asymmetry in p^{↑}+p→W^{±}/Z^{0} at RHICL Adamczyk, J K Adkins, G Agakishiev, et al.
Pageof 92